News

11.21.2022

Sheppard Mullin’s Corporate practice has been busy closing a variety of deals and transactions over the past few months:

Financings

• Represented New York-based healthcare private equity firm SIGNET Healthcare Partners in its investment in LAXAI Inc., an integrated provider of drug discovery, development and manufacturing services for pharmaceutical and specialty chemical companies. The deal team was led by Shon Glusky, Amanda Ackerman and Josh McLane. Special assistance was provided by Mark Kahn, Fatema Merchant, Christina Nguyen, Neil Popović and Brian Weimer. (October 24)

Mergers & Acquisitions

• Advised Advanced Marine Preservation (AMP) in its sale to Armada Parent, Inc. ("Armada"), a portfolio company of global investment firm Carlyle and Stellex Capital Management. AMP provides critical preservation services through large prime contractors, primarily to the U.S. Navy in maintaining its small surface war ships, as the nation seeks to meet increasing pressures to assure the Nation's defense readiness in a growingly challenging world. The deal team was led by Shon Glusky, Matt Silverstein, Cristina Nguyen, Carol Archer and Niya Tang. Special assistance was provided by Julia Kadish, Michael Chan, Keith Szeliga, Sean Kirby, Carlo Van den Bosch, Michael Leake, Olivier Theard and James Hays. (October 24)
• Represented Allied Universal, the leading global security and facility services company, in its acquisition of Century Event Security & Staffing, which provides comprehensive security and event services in Las Vegas and Orlando. The deal was led by Steve LaSala and Brandon Beshay. (October 14)
• Advised Avisa Partners SAS, a portfolio company of Raise Investissement SAS and Rives Croissance SAS, in its acquisition of Forward Risk and Intelligence LLC, a firm that conducts investigative due diligence, business intelligence research and international risk assessments for investors, corporations and law firms. The deal was led by Valérie Demont, Karl Buhler and Anushna Das and included Dmitriy Chelnitsky, Wynter Deagle, Niya Tang, Dan Yannuzzi, John Hempill, Sean Kirby, Malika Levarlet, Evan Lim, Betsy Luxenberg, Michael Weisshar and Nirav Bhatt. (November 16)
• Represented Sia Partners in its acquisition of Latham Biopham, which specializes in helping pharma, biotech and medical device firms secure non-dilutive funding from US government agencies and NGOs. The deal team was led by Valérie Demont, Joseph Schemo and Erin Hausladen. Special assistance was provided by Sean Kirby, Michael Chan, Dan Yannuzzi, Wynter Deagle, Reid Whitten, David Gallacher, Dmitriy Chelnitsky, Niya Tang, Sara Shanti, Malika Levarlet, Evan Lim, Michael Weisshar and Betsy Luxenberg. (October 14)

Public Offerings

• Advised Aditxt, Inc., a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, in a $20 million follow on Public Offering. The deal team was led by Richard Friedman, Sean Reid and Emily Mastoloni. (September 20)
• Represented the Issuer in connection with Amesite, Inc.’s $2.3 million Public Offering of Common Stock. The deal team included Richard Friedman, Sean Reid and Hannah Zelcer. (September 1)
• Advised the Issuer in connection with Mobile Global Esports’ $5.0 million Private Placement of Common Stock and Warrants. The deal team included Richard Friedman, Edwin Astudillo and Emily Mastoloni. (September 20)
• Represented Laidlaw and Company as Placement Agent in connection with NLS Pharmaceuticals Ltd.’s $4.0 million Private Placement of Common Shares and Warrants. The deal team was led by Richard Friedman, Stephen Cohen and Gregory Carney. (September 30)
• Represented the Issuer in connection with Silo Pharma, Inc.’s $5.75 million Public Offering of Common Stock and Listing on the Nasdaq Capital Market. The deal team included Richard Friedman, Gregory Carney and Hannah Zelcer. (September 29)